Physician profile
Christopher John Thrash
NPI 1821225228
$774.12
in general payments reported to CMS, 2019-2025
17 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $17.25 · 2021: $32.32 · 2022: $177 · 2023: $116 · 2024: $44.04 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $214.42 | 2019-2025 | |
| Currax Pharmaceuticals LLC | $78.77 | 2022-2023 | Contrave |
| Astrazeneca Pharmaceuticals LP | $67.38 | 2019-2025 | Breztri |
| Boston Scientific Corporation | $66.29 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $59.32 | 2019-2024 | Xarelto |
| Sumitomo Pharma America, INC. | $46.42 | 2025 | Gemtesa |
| Amgen INC. | $42.02 | 2019-2025 | Evenity |
| Acadia Pharmaceuticals INC | $28.77 | 2025 | Nuplazid |
| Eisai INC. | $27.69 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.81 | 2019 | |
| Exact Sciences Corporation | $24.74 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $21.95 | 2023 | Mounjaro |
| Glaxosmithkline, LLC. | $17.25 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.67 | 2022 | |
| Therapeuticsmd, INC. | $14.16 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.27 | 2023 | Ubrelvy |
| Sanofi Pasteur INC. | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Thrash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.